Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | FABP3 | P05413 | 2/20 | 0.49 |
| ▸ | SNCA | P37840 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | FABP4 | P15090 | 1/20 | 0.47 |
| ▸ | HTR1D | P28221 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1694563 | 0.92 | LMNA (0.56) | TSHRTP53CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL3161189 | 0.86 | MEN1 (0.58) | TSHRTP53CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL21381328 | 0.83 | MAPT (0.61) | TSHRTP53CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6313773 | 0.81 | PTGDR2 (0.53) | TSHRTP53CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL3168428 | 0.81 | MEN1 (0.57) | TP53CYP1A2CYP2D6CYP2C19TDP1 | |
| SCHEMBL9780586 | 0.81 | KMT2A (0.65) | TSHRCYP3A4KMT2AL3MBTL1FABP3 | |
| SCHEMBL692136 | 0.81 | KMT2A (0.65) | TSHRCYP2C19TDP1KMT2AALDH1A1 | |
| SCHEMBL14052680 | 0.80 | KMT2A (0.50) | TSHRTP53CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9322243 | 0.80 | MEN1 (0.55) | TP53CYP1A2CYP2D6CYP2C19TDP1 | |
| Water SCHEMBL28856010 | 0.79 | KMT2A (0.62) | TSHRTDP1KMT2AALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119876042-A | Hybridoma cell strain 24DB-8E7 and anti-2, 4-dichlorophenoxybutyric acid antibody produced by same | 闽南师范大学 | 2025-04-25 | — | — | CN | claimed |
| CN-102480936-A | Herbicidal concentrate compositions containing glyphosate salt and dicamba salt | DOW AGROSCIENCES LLC | 2012-05-30 | — | — | CN | claimed |
| WO-2005063962-A1 | SYSTEM FOR COMMINUTING, EXTRACTING AND DETECTING ANALYTES IN SOLD BIOLOGICAL SAMPLES | DRUG RISK SOLUTIONS, INC. (US) | 2005-07-14 | — | — | WO | claimed |
| CN-119876042-A | Hybridoma cell strain 24DB-8E7 and anti-2, 4-dichlorophenoxybutyric acid antibody produced by same | 闽南师范大学 | 2025-04-25 | — | — | CN | disclosed |
| EP-2714675-B1 | 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE | LEXICON PHARMACEUTICALS INC (US) | 2019-01-02 | — | — | EP | disclosed |
| EP-2714675-B1 | 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE | LEXICON PHARMACEUTICALS INC (US) | 2019-01-02 | — | — | EP | disclosed |
| US-9624238-B2 | 4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use | LEXICON PHARMACEUTICALS, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-9624238-B2 | 4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use | LEXICON PHARMACEUTICALS, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| US-9624238-B2 | 4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use | LEXICON PHARMACEUTICALS, INC. (US) | 2017-04-18 | — | — | US | disclosed |
| CN-104761521-A | Biphenyl-Substituted Spirocyclic Ketoenols | BAYER CROPSCIENCE AG | 2015-07-08 | — | — | CN | disclosed |
| US-20140256784-A1 | 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2014-09-11 | — | — | US | disclosed |
| CN-102408326-A | Biphenyl-substituted spirocyclic ketoenols | BAYER CROPSCIENCE AG | 2012-04-11 | — | — | CN | disclosed |
| CN-101547899-A | Biphenyl-substituted spirocyclic keto-enols | BAYER CROPSCIENCE AG (DE) | 2009-09-30 | — | — | CN | disclosed |
| WO-2008156654-A2 | CYTOSKELETON MODULATORS FOR TREATING METABOLIC DISORDERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-12-24 | — | — | WO | disclosed |
| WO-2005063962-A1 | SYSTEM FOR COMMINUTING, EXTRACTING AND DETECTING ANALYTES IN SOLD BIOLOGICAL SAMPLES | DRUG RISK SOLUTIONS, INC. (US) | 2005-07-14 | — | — | WO | disclosed |
| WO-2005039381-A2 | COMPOSITIONS AND PROCESSES FOR ANALYSIS OF PHARMACOLOGIC AGENTS IN BIOLOGICAL SAMPLES | DRUG RISK SOLUTIONS, L.L.C. (US) | 2005-05-06 | — | — | WO | disclosed |
| EP-1521833-A2 | SYNTHETIC HERBICIDE RESISTANCE GENE | The United States of America, represented by The Secretary of Agriculture (US) | 2005-04-13 | — | — | EP | disclosed |
| US-20050037386-A1 | Composition and processes for analysis of pharmacologic agents in biological samples | DRUG RISK SOLUTIONS, L.L.C. | 2005-02-17 | — | — | US | disclosed |
| WO-2003034813-A2 | SYNTHETIC HERBICIDE RESISTANCE GENE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2003-05-01 | — | — | WO | disclosed |
| US-4071617-A | VINYL ALCOHOL-VINYL ACETATE COPOLYMER | CHEVRON RESEARCH COMPANY (US) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256784-A1 | 4H-THIENO[3,2-C]CHROMENE-BASED INHIBITORS OF NOTUM PECTINACETYLESTERASE AND METHODS OF THEIR USE | NOTUM, CES1, ACHE | TSHR 3034/4885TP53 3658/4885CYP1A2 301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.